Advanced search
Publication Cover
Open Access Journal of Clinical Trials Volume 4, 2012 - Issue
Submit an article Journal homepage
47
Views
3
CrossRef citations to date
0
Altmetric
Methodology

A randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design

Thomas D Boyer1 Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA
,
Joseph J Medicis2 Research and Development, Ikaria, Hampton, NJ, USA
,
Stephen Chris Pappas3 Orphan Therapeutics, Lebanon, NJ, USA
,
Jim Potenziano2 Research and Development, Ikaria, Hampton, NJ, USA
&
Khuramm Jamil2 Research and Development, Ikaria, Hampton, NJ, USACorrespondence[email protected]
Pages 39-49 | Published online: 16 Jul 2012

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Khurram Jamil, S Chris Pappas, Florence Wong & Arun J Sanyal. (2019) Verified Hepatorenal Syndrome Reversal As A Robust Multi-Component Primary End Point: The CONFIRM Study Trial Design. Open Access Journal of Clinical Trials 11, pages 67-73.
Read now

Articles from other publishers (2)

Irtiza Hasan, Tasnuva Rashid, Razvan M Chirila, Peter Ghali & Hani M. Wadei. (2021) Hepatorenal syndrome: pathophysiology and evidence-based management update. Romanian Journal of Internal Medicine 59:3, pages 227-261.
Crossref
Eman Ibrahim El-Desoki Mahmoud, Doaa H Abdelaziz, Sherief Abd-Elsalam & Noha O. Mansour. (2021) Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial. Frontiers in Pharmacology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.